PYY (3-36), a Y2 receptor agonist, is released from the body's gastrointestinal tract in proportion to caloric intake. It has been shown that peripheral injection of PYY (3-36) in rats inhibited food intake and reduced weight gain. In addition, infusion of PYY (3-36) in humans significantly decreased appetite and reduced food intake by 33% over 24h, which suggests that PYY (3-36) has a role in 'longer term' regulation of food intake. Thus, the PYY (3-36) may represent a lead compound for the development of drugs for the treatment of obesity.
R.L.Batterham et al., N. Engl. J. Med., 349, 941 (2003).
I.G.Halatchev and R.D.Cone, Cell Metab., 1, 159 (2005)
PK Chelikani, et al, Am. J Phyiol Regul Integr Comp Physiol,, 293, R39, (2007).
G.H.Ballantyne, Obes. Surg., 16, 651 (2006).
C.Acuna-Goycolea and A.N.van den Pol, J. Neurosci., 25, 10510 (2005).
Y.Shechter et al., FEBS Lett., 579, 2439 (2005).
R.L.Batterham et al., Nature, 418, 650 (2002).
D.Grandt et al., Regul. Peptides, 40, 161 (1992).
BIOLEAF热搜 BIOLEAF试剂盒 BIOLEAF ELISA BIOLEAF试剂 BIOLEAF品牌 BIOLEAF抗体 BIOLEAF耗材 BIOLEAF小仪器
sitemap 细胞库查询 危险品图标 本公司网站所展示销售的产品仅供科研！
沪公网安备 31011202007338号